Literature DB >> 3019881

Nucleotide sequence of cDNA and derived amino acid sequence of rabbit complement component C3 alpha-chain.

M Kusano, N H Choi, M Tomita, K Yamamoto, S Migita, T Sekiya, S Nishimura.   

Abstract

The nucleotide sequence coding for 726 amino acid residues of the alpha-chain of rabbit C3 was determined from a cDNA clone. Subfragments of the cDNA produced by restriction endonucleases were inserted into the bacteriophage M13 and sequenced using the dideoxynucleotide technique. The derived amino acid sequence was compared with those of human and mouse C3, which have been previously reported [by De Brujn, M.H.L. and Fey, G.H. (1985) Proc. Natl. Acad. sci. USA 82, 708, and Westel, R.A. et al. (1984) J. Biol. chem. 259, 13857, respectively]. There was 79% or 78% homology in amino acid sequence between rabbit and human or mouse C3, respectively. All of the cysteinyl residues were conserved among the three molecules, and the sequence around the thioester site was also highly conserved. Several regions having low homology were found: one of them was the small fragment released by factor I cleavage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019881     DOI: 10.3109/08820138609052955

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  3 in total

1.  Conservation of structural and functional domains in complement component C3 of Xenopus and mammals.

Authors:  D Grossberger; A Marcuz; L Du Pasquier; J D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

2.  Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.

Authors:  Ulf R Nilsson; Lillemor Funke; Bo Nilsson; Kristina N Ekdahl
Journal:  Ups J Med Sci       Date:  2010-11-11       Impact factor: 2.384

3.  The structure of an alternate form of complement C3 that displays costimulatory growth factor activity for B lymphocytes.

Authors:  Y Cahen-Kramer; I L Mårtensson; F Melchers
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.